Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1086138 | Le Pharmacien Hospitalier | 2006 | 10 Pages |
Abstract
Since few years, caring for chronic heart failure has been improved with the perfect of resynchronization therapy : it uses triple chamber implantable cardiac pacemaker, called « multisite ». This therapy consists of an atrio- biventricular pacing of the heart. The development of those devices comes after several studies started in early 90's. The latter allowed technology's devices to progress and to have a well targeted indication. However, several points had to be cleared up for a better selection of patient who had a good response with treatment. Since few time, in France, legislation of those devices is in place : it defines precisely the framework of their use and the conditions of their caring by Social security.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Muriel Pourrat, Christelle Marquie, Salem Kacet, Isabelle Walbecq,